188 related articles for article (PubMed ID: 22339280)
1. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
Hong H; Yang K; Zhang Y; Engle JW; Feng L; Yang Y; Nayak TR; Goel S; Bean J; Theuer CP; Barnhart TE; Liu Z; Cai W
ACS Nano; 2012 Mar; 6(3):2361-70. PubMed ID: 22339280
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of CD105 expression during tumor angiogenesis.
Hong H; Yang Y; Zhang Y; Engle JW; Barnhart TE; Nickles RJ; Leigh BR; Cai W
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1335-43. PubMed ID: 21373764
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.
Zhang Y; Hong H; Orbay H; Valdovinos HF; Nayak TR; Theuer CP; Barnhart TE; Cai W
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):759-67. PubMed ID: 23344138
[TBL] [Abstract][Full Text] [Related]
4. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.
Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852
[TBL] [Abstract][Full Text] [Related]
5. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W
PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762
[TBL] [Abstract][Full Text] [Related]
7. VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.
Shi S; Yang K; Hong H; Chen F; Valdovinos HF; Goel S; Barnhart TE; Liu Z; Cai W
Biomaterials; 2015 Jan; 39():39-46. PubMed ID: 25477170
[TBL] [Abstract][Full Text] [Related]
8. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
[TBL] [Abstract][Full Text] [Related]
9. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
Shi S; Orbay H; Yang Y; Graves SA; Nayak TR; Hong H; Hernandez R; Luo H; Goel S; Theuer CP; Nickles RJ; Cai W
J Nucl Med; 2015 Jun; 56(6):927-32. PubMed ID: 25883125
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.
Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice.
Karmani L; Levêque P; Bouzin C; Bol A; Dieu M; Walrand S; Vander Borght T; Feron O; Grégoire V; Bonifazi D; Michiels C; Lucas S; Gallez B
Nucl Med Biol; 2016 Jul; 43(7):415-23. PubMed ID: 27179250
[TBL] [Abstract][Full Text] [Related]
12.
Ehlerding EB; Ferreira CA; Aluicio-Sarduy E; Jiang D; Lee HJ; Theuer CP; Engle JW; Cai W
Mol Pharm; 2018 Jul; 15(7):2606-2613. PubMed ID: 29787283
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeling of monoclonal anti-CD105 with (177)Lu for potential use in radioimmunotherapy.
Lee SY; Hong YD; Felipe PM; Pyun MS; Choi SJ
Appl Radiat Isot; 2009; 67(7-8):1366-9. PubMed ID: 19324561
[TBL] [Abstract][Full Text] [Related]
14. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene.
Hong H; Zhang Y; Engle JW; Nayak TR; Theuer CP; Nickles RJ; Barnhart TE; Cai W
Biomaterials; 2012 Jun; 33(16):4147-56. PubMed ID: 22386918
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.
Hong H; Zhang Y; Orbay H; Valdovinos HF; Nayak TR; Bean J; Theuer CP; Barnhart TE; Cai W
Mol Pharm; 2013 Feb; 10(2):709-16. PubMed ID: 23316869
[TBL] [Abstract][Full Text] [Related]
16. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.
Shi S; Yang K; Hong H; Valdovinos HF; Nayak TR; Zhang Y; Theuer CP; Barnhart TE; Liu Z; Cai W
Biomaterials; 2013 Apr; 34(12):3002-9. PubMed ID: 23374706
[TBL] [Abstract][Full Text] [Related]
17. Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.
Chen F; Hong H; Shi S; Goel S; Valdovinos HF; Hernandez R; Theuer CP; Barnhart TE; Cai W
Sci Rep; 2014 May; 4():5080. PubMed ID: 24875656
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
Fonsatti E; Nicolay HJ; Altomonte M; Covre A; Maio M
Cardiovasc Res; 2010 Apr; 86(1):12-9. PubMed ID: 19812043
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice.
Tsujie M; Tsujie T; Toi H; Uneda S; Shiozaki K; Tsai H; Seon BK
Int J Cancer; 2008 May; 122(10):2266-73. PubMed ID: 18224682
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W
ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
